Moleculin Biotech Inc

Our certificate of incorporation provides that the Court of Chancery of the State of Delaware shall be the sole and exclusive forum for (i) any derivative action or proceeding brought our behalf, (ii) any action asserting a claim of breach of a fiduciary duty owed by any of our directors or officers to us or our stockholders, (iii) any action asserting a claim against us arising pursuant to any provision of the Delaware General Corporation Law, or our certificate of incorporation or the bylaws, and (iv) any action asserting a claim against us governed by the internal affairs doctrine. This provision wouldnot apply to suits brought to enforce a duty or liability created by the Exchange Act or Securities Act.

This choice of forum provision* maylimit a stockholder’s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or our directors, officers or other employees, which maydiscourage such lawsuits against us and our directors, officers and employees. Alternatively, a court could find these provisions of our certificate of incorporation to be inapplicable or unenforceable in respect ofone* or more of the specified types of actions or proceedings, which* may*require us to incur additional costs associated with resolving such matters in other jurisdictions, which could adversely affect our business and financial.

During thethree months ended* December 31, 2023,no director or officer of the Company adopted or terminated a "Rule10b5*-1 trading arrangement” or “non-Rule10b5-1 trading arrangement,” as each term is defined in Item408(a) of Regulation S-K.